Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学AML, Venetoclax Combinations

Andrew Wei

MBBS, PhD

🏢Peter MacCallum Cancer Centre🌐Australia

Professor and Clinical Hematologist

78
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Andrew Wei co-led the VIALE-A trial demonstrating that venetoclax plus azacitidine improved survival in older patients with acute myeloid leukemia unfit for intensive chemotherapy. His work established a new standard of care in frontline AML and guides ongoing efforts in minimal residual disease-directed therapy. He leads collaborative Australasian trials in AML.

Share:

🧪Research Fields 研究领域

AML
venetoclax
azacitidine
VIALE-A
elderly leukemia

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Andrew Wei 的研究动态

Follow Andrew Wei's research updates

留下邮箱,当我们发布与 Andrew Wei(Peter MacCallum Cancer Centre)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment